Data as of Sep 17
| +1.28 / +3.95%|
The 10 analysts offering 12-month price forecasts for Aegerion Pharmaceuticals Inc have a median target of 63.50, with a high estimate of 107.00 and a low estimate of 27.00. The median estimate represents a +88.48% increase from the last price of 33.69.
The current consensus among 10 polled investment analysts is to Buy stock in Aegerion Pharmaceuticals Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.